CEA TCB: A novel head-to-tail 2:1 T cell bispecific antibody for treatment of CEA-positive solid tumors

類似資料

• Cross-linking of T cell to B cell lymphoma by the T cell bispecific antibody CD20-TCB induces IFNγ/CXCL10-dependent peripheral T cell recruitment in humanized murine model
  著者:: Cremasco, Floriana, 等
  出版事項: (2021)
• CEA expression heterogeneity and plasticity confer resistance to the CEA-targeting bispecific immunotherapy antibody cibisatamab (CEA-TCB) in patient-derived colorectal cancer organoids
  著者:: Reyes Gonzalez-Exposito, 等
  出版事項: (2019-04-01)
• CEA expression heterogeneity and plasticity confer resistance to the CEA-targeting bispecific immunotherapy antibody cibisatamab (CEA-TCB) in patient-derived colorectal cancer organoids
  著者:: Gonzalez-Exposito, Reyes, 等
  出版事項: (2019)
• Recent advances of bispecific antibodies in solid tumors
  著者:: Yu, Shengnan, 等
  出版事項: (2017)
• A Novel T Cell-Engaging Bispecific Antibody for Treating Mesothelin-Positive Solid Tumors
  著者:: Aerin Yoon, 等
  出版事項: (2020-03-01)